A vaccine platform using RNA replicon vectors derived from attenuated alphavirus strains to induce immune responses against infectious diseases and cancers.

Vaccines developed using alphavaccine technology to stimulate the immune system to recognize and attack cancer cells in various cancers including prostate, breast, and gastrointestinal cancers.